1 / 8

Asthma Spacers Market is projected to grow US$ 2,266.47 million by 2028

asthma spacers market is projected to grow from US$ 1,666.48 million in 2022 to US$ 2,266.47 million by 2028; it is estimated to grow at a CAGR of 5.3% from 2022 to 2028. Asthma spacers are an external device that provides better drug delivery by increasing inhalation and actuation.<br><br>For more info..<br>https://www.theinsightpartners.com/reports/asthma-spacers-market/utm_source=freeplatform&utm_medium=10726

Sanket15
Télécharger la présentation

Asthma Spacers Market is projected to grow US$ 2,266.47 million by 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Asthma Spacers Market Global Analysis and Forecast to 2028 Published Date : May 2022 Email: sales@theinsightpartners.com

  2. Email:sales@theinsightpartners.com Report Studies • Asthma Spacers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Aerochamber, Optichamber, Volumatic, and Inspirease) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Commerce)

  3. Email:sales@theinsightpartners.com Asthma Spacers Market Value CAGR of 5.3% (2022 - 2028)

  4. Email:sales@theinsightpartners.com Asthma Spacers Market Overview • The asthma spacers market is projected to grow from US$ 1,666.48 million in 2022 to US$ 2,266.47 million by 2028; it is estimated to grow at a CAGR of 5.3% from 2022 to 2028. • Asthma spacers are an external device that provides better drug delivery by increasing inhalation and actuation. Spacers helps in administrering right amount of medicine to the lungs when used along with the metered dose inhaler (MDI). The application of asthma spacer helps in reducing the waste of medicine and also restricts the occurrence of dose associated adverse events. Asthma is a chronic respiratory disorder that affects the lungs' airways by variable and recurring symptoms such as chest tightness, shortness of breath, wheezing, and coughing. Most of the time, it is very difficult to distinguish asthma from COPD in elderly patients due to similar clinical features, while reoccurrence of asthma is a major problem in younger patients. Genetic factors strongly influence the development of the disease.

  5. Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Product (Aerochamber, Optichamber, Volumatic, and Inspirease) • By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Commerce)

  6. Email:sales@theinsightpartners.com Company Profiles • Cipla Inc. • PARI GmbH • Koninklijke Philips N.V. • Lupin • LaboratoireProtecSom • Monaghan Medical Corporation • Koo Medical Equipment • Agaplastic • Teleflex Incorporated • Metall Zug Download Sample Here

  7. Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  8. THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related